Litigation Details for In Re: Application of Biogen MA, Inc. for issuance of a subpoena under 28 U.S.C. § 1782 (D. Del. 2023)
✉ Email this page to a colleague
In Re: Application of Biogen MA, Inc. for issuance of a subpoena under 28 U.S.C. § 1782 (D. Del. 2023)
Docket | ⤷ Sign Up | Date Filed | 2023-05-15 |
Court | District Court, D. Delaware | Date Terminated | 2023-05-22 |
Cause | 28:1782 Letter rogatory - appointment | Assigned To | Gregory B. Williams |
Jury Demand | None | Referred To | |
Parties | SANDOZ, INC. | ||
Patents | 10,119,976 | ||
Attorneys | Samantha G. Wilson | ||
Firms | Young, Conaway, Stargatt & Taylor LLP | ||
Link to Docket | External link to docket |
Biologic Drugs cited in In Re: Application of Biogen MA, Inc. for issuance of a subpoena under 28 U.S.C. § 1782
Details for In Re: Application of Biogen MA, Inc. for issuance of a subpoena under 28 U.S.C. § 1782 (D. Del. 2023)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2023-05-15 | 3 | Memorandum in Support | ,794, 10,119,976, and 10,677,803 cover subject matter similar to EP 792 and relate to methods of evaluating…asserts 17 US patents. None of these patents are in the same family as EP 792. However, US Patents 11,280,794…. C. Biogen’s Assay Patents. Biogen owns several patents relating to methods of evaluating… a European patent (“EP 792”) and a divisional application pending in the European Patent Office are …and UK Patent Litigation and the Need for Further Discovery Biogen has asserted patents related | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |